Other Aliphatic rings

• 

  3-cyanopyrrolidine-3-carboxylic acid hydrochloride

  AD1527681205748-98-690%
• 

  rac-(3R,4R)-4-(difluoromethyl)pyrrolidine-3-carboxylic acid hydrochloride, trans

  AD1525651394040-69-790%
• 

  3-hydroxypyrrolidine-3-carboxylic acid hydrochloride

  AD15253567117-23-190%
• 

  2-[(azetidin-3-yl)(methyl)amino]acetic acid dihydrochloride

  AD1525192416234-14-390%
• 

  4-methyl-5-oxopiperazine-2-carboxylic acid hydrochloride

  AD1522342155852-15-490%
• 

  2-methylmorpholine-2-carboxylic acid hydrochloride

  AD1521522137719-42-590%
• 

  2-(4-ethylpiperazin-1-yl)ethanimidamide dihydrochloride

  AD1519192490435-76-090%
• 

  methyl 5-iminopyrrolidine-3-carboxylate hydrochloride

  AD1519122361635-93-890%
• 

  1,4-oxazepan-3-one

  AD15180861108-69-890%
• 

  (4aR,7aS)-octahydrofuro[3,4-b]pyrazine-2,3-dione, cis

  AD1517461310377-79-790%
• 

  rac-(3R,4R)-3,4-dimethylpyrrolidin-2-one, trans

  AD15173613128-93-390%
• 

  N,N-dimethyl-5-oxopyrrolidine-3-carboxamide

  AD151732958807-10-890%
• 

  2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)acetamide

  AD151403211248-43-090%
• 

  4-(hydroxymethyl)azetidin-2-one

  AD15139074694-48-790%
• 

  1-methyl-5-oxopyrrolidine-3-carboxamide

  AD15129189677-16-790%
• 

  4-methoxypyrrolidin-2-one

  AD15127489417-37-890%
• 

  3-(2-bromoethyl)-1,3-oxazolidin-2-one

  AD15083289869-36-390%
• 

  2-bromo-3-methyl-1-(morpholin-4-yl)butan-1-one

  AD1507756627-99-290%
• 

  tert-butyl 4-(2-chloroacetyl)-3-methylpiperazine-1-carboxylate

  AD1503151353975-27-590%
• 

  3-(2-bromoethyl)-1-methylazetidine hydrobromide

  AD1502911803591-34-590%